MichaelRobertCampoliMD

PubMed

• 4 citations
  Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous ...
  Ryan B. Thorpe, Kyle R. Covington, Hillary G. Caruso, Ann P. Quick, Olga Zolochevska, Gregory M. Bricca, Michael Campoli, James R. DeBloom, Michael J. Fazio, Bradley N...> ;Journal of the American Academy of Dermatology. 2021 Nov 19
• 36 citations
  Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective coho...
  Amanda J. Tschetter, Michael Campoli, John A. Zitelli, David G. Brodland> ;Journal of the American Academy of Dermatology. 2020 Jan 1
• 40 citations
  A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.
  Michael Campoli, David G. Brodland, John A. Zitelli> ;Journal of the American Academy of Dermatology. 2014 Apr 1
• 32 citations
  HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition
  Michael Campoli, Soldano Ferrone> ;Seminars in Immunopathology. 2011 Apr 28
• 6 citations
  HLA antigen expression in melanocytic lesions: Is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?
  Michael Campoli, James E. Fitzpatrick, Whitney A. High, Soldano Ferrone> ;Journal of the American Academy of Dermatology. 2012 Jun 1
• 95 citations
  CSPG4 in Cancer: Multiple Roles
  Xiao-hong Wang, Yangyang Wang, Ling Yu, Koichi Sakakura, Carmen Visus, Joseph H. Schwab, Cristina R. Ferrone, Elvira Favoino, Y. Koya, M.R. Campoli, James B. McCarthy,...> ;Current Molecular Medicine. 2010 May 31
• 89 citations
  Functional and clinical relevance of chondroitin sulfate proteoglycan 4.
  Michael Campoli, Soldano Ferrone, Xinhui Wang> ;Advances in Cancer Research. 2010 Jan 1
• 57 citations
  Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.
  Michael Campoli, Robert L. Ferris, Soldano Ferrone, Xinhui Wang> ;Clinical Cancer Research. 2010 Jan 1
• 297 citations
  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
  Michael Campoli, Soldano Ferrone> ;Oncogene. 2008 Oct 6
• 58 citations
  Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.
  Michael Campoli, Soldano Ferrone> ;Tissue Antigens. 2008 Oct 1
• 143 citations
  Human Leukocyte Antigen and Antigen Processing Machinery Component Defects in Astrocytic Tumors
  Angelica Facoetti, Rosanna Nano, Paola Zelini, Patrizia Morbini, E. Benericetti, Mauro Ceroni, Michael Campoli, Soldano Ferrone> ;Clinical Cancer Research. 2005 Dec 1
• 22 citations
  Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions
  Toshiro Kageshita, T. Ishihara, Michael Campoli, Soldano Ferrone> ;Tissue Antigens. 2005 May 1
• 54 citations
  A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections
  Xinhui Wang, Michael Campoli, Hyun Suk Cho, Takeshi Ogino, Nobuyuki Bandoh, Jijia Shen, Soo Young Hur, Toshiro Kageshita, Soldano Ferrone> ;Journal of Immunological Methods. 2005 Apr 1
• 80 citations
  Immune Selection of Hot-Spot β2-Microglobulin Gene Mutations, HLA-A2 Allospecificity Loss, and Antigen-Processing Machinery Component Down-Regulation in Melanoma Cells...
  Chien-Chung Chang, Michael Campoli, Nicholas P. Restifo, Xinhui Wang, Soldano Ferrone> ;Journal of Immunology. 2005 Feb 1
• 48 citations
  Mechanisms of tumor evasion.
  Michael Campoli, Soldano Ferrone, Arnold H. Zea, Paulo C. Rodriguez, Augusto C. Ochoa> ;Cancer Treatment and Research. 2005 Jan 1
• 87 citations
  Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.
  Chien-Chung Chang, Michael Campoli, Soldano Ferrone> ;Advances in Cancer Research. 2005 Jan 1
• 144 citations
  Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical signifi...
  Michael Campoli, Chien-Chung Chang, Toshiro Kageshita, Xinhui Wang, James B. McCarthy, Soldano Ferrone> ;Critical Reviews in Immunology. 2004 Jan 1
• 29 citations
  Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.
  Chien-Chung Chang, Michael Campoli, Wei Luo, Wanzhou Zhao, Kurt S. Zaenker, Soldano Ferrone> ;Annals of the New York Academy of Sciences. 2004 Dec 1
• 19 citations
  Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies
  Xinhui Wang, Michael Campoli, Eric C. Ko, Wei Luo, Soldano Ferrone> ;Journal of Immunological Methods. 2004 Nov 1
• 35 citations
  HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
  Chien-Chung Chang, Michael Campoli, Soldano Ferrone> ;Current Opinion in Immunology. 2004 Oct 1
• 4 citations
  T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?
  Michael Campoli, Soldano Ferrone> ;Expert Review of Vaccines. 2004 Apr 1
• 22 citations
  HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications.
  Michael Campoli, Chien-Chung Chang, Sharon A. Oldford, Allison D. Edgecombe, Sheila Drover, Soldano Ferrone> ;Breast Disease. 2004 Jan 1
• 56 citations
  HLA class I defects in malignant lesions: what have we learned?
  Chien-Chung Chang, Michael Campoli, Soldano Ferrone> ;The Keio Journal of Medicine. 2003 Dec 1
• 94 citations
  HLA class I antigen loss, tumor immune escape and immune selection.
  Michael Campoli, Chien-Chung Chang, Soldano Ferrone> ;Vaccine. 2002 Dec 19
• Predictors of clinical efficacy of ''Ablate and Pace'' therapy in patients with permanent atrial fibrillation.
  Brignole, M., Botto, G. L., Mont, L., Oddone, D., Iacopino, S., De Marchi, G., Campoli, M., Sebastiani, V., Vincenti, A., Garcia Medina, D., Osca Asensi, J., Mocini, A...> ;Heart. 2012 Feb
• Join now to see all